CaRi-heart technology
Revolutionary new technology to assess the risk of a serious heart condition or heart attack – many years before anything happens.
Private Immunotherapy treatment
PROVIDED BY HCA UK IN THEIR CANCER CENTRES IN LONDON, BIRMINGHAM AND MANCHESTER
Immunotherapy is a type of cancer treatment that helps your own immune system fight cancer.
Immunotherapy at HCA UK
We ensure that you have rapid access to our range of immunotherapy treatments. Immunotherapy is only available for certain types of cancers, your consultant specialist can advise you on if immunotherapy may be a suitable treatment option for you.
We continue to be at the forefront of innovative cancer treatments and work with leading cancer specialists to adopt the latest treatment techniques. No two treatment plans are the same. We take a patient-focused approach, working with you to determine what’s best.
Our highly skilled multidisciplinary team are on hand to help you make those all-important decisions, so you get the right treatment. Immunotherapy can be stressful for cancer patients and their family. Our aim is to help you stay strong, manage side effects and support you through the difficult stages of treatment and recovery.
A closer look at immunotherapy
There are many different types of immunotherapy. Some boost the immune system, helping your body attack cancer cells. Other types are designed to slow down the proteins that help cancer cells grow. Types include:
- Monoclonal antibodies (MABs)
- Checkpoint inhibitors
- Cytokines
- CAR-T cell therapy
Immunotherapy can be used as a stand-alone treatment in combatting cancer cells, or it can be used alongside other treatments to strengthen the immune system’s response. This break-through therapy has the potential to treat a broad spectrum of patients.
Depending on the stage and type of tumour, your consultant will identify whether immunotherapy is suitable for you.
No matter what type or stage of cancer, we’re here to listen and make sure that you are well-looked after in every way. We pride ourselves on treating all of our patients like family. HCA UK will support you throughout the entire pathway, from diagnosis and treatment, through to survivorship and aftercare.
“I can do things I didn’t even dare to dream I would ever be able to do again”
Our Private Immunotherapy treatment locations
London Bridge Hospital
27 Tooley Street SE1 2PR London
HCA Healthcare UK at University College Hospital
Grafton Way Building, 1 Grafton Way WC1E 6AG London
Leaders in Oncology Care
95-97 Harley Street W1G 6AF London
Patient stories
Yvette's story: From back pain to hip replacement surgery
Yvette (54) a journalist from Kent, started experiencing pain in her hip seven years ago in 2015. An ex-national gymnast who had been incredibly active and flexible her whole life, Yvette felt concerned about the growing discomfort impacting her quality of life, and so sought help from her GP.
A new hip and straight back into the spin of things
David’s gym video shows him repeatedly pushing up to 100kg on a single leg press – not particularly unusual for this keen cyclist, former competitive squash player and all-round fitness enthusiast. What is unusual is that 52-year-old David had hip surgery just 12 weeks earlier.
Michael's MAKO hip surgery to treat his arthritis
73 year-old Michael, an avid walker and charity worker, was diagnosed with arthritis in January 2021. After facing long waiting times and increasing pain that was becoming more frequent, he started to look elsewhere for treatment.
This content is intended for general information only and does not replace the need for personal advice from a qualified health professional.
Immunotherapy clinical trials
There are number of clinical trials open for immunotherapy to treat other types of cancer.
At HCA Healthcare UK, we are committed to providing and helping to develop the latest immunotherapy treatments. Our network of hospitals provide access to a wide range immunotherapy treatments, and our drug development unit, Sarah Cannon Research Institute, has a number of open trials in immunotherapy.